300 related articles for article (PubMed ID: 30509693)
1. Immunogenicity of synthetic peptide constructs based on PvMSP9
Rodrigues-da-Silva RN; Correa-Moreira D; Soares IF; de-Luca PM; Totino PRR; Morgado FN; Oliveira Henriques MDG; Peixoto Candea AL; Singh B; Galinski MR; Moreno A; Oliveira-Ferreira J; Lima-Junior JDC
Vaccine; 2019 Jan; 37(2):306-313. PubMed ID: 30509693
[TBL] [Abstract][Full Text] [Related]
2. In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.
Rodrigues-da-Silva RN; Martins da Silva JH; Singh B; Jiang J; Meyer EV; Santos F; Banic DM; Moreno A; Galinski MR; Oliveira-Ferreira J; Lima-Junior Jda C
PLoS One; 2016; 11(1):e0146951. PubMed ID: 26788998
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.
Oliveira-Ferreira J; Vargas-Serrato E; Barnwell JW; Moreno A; Galinski MR
Vaccine; 2004 May; 22(15-16):2023-30. PubMed ID: 15121316
[TBL] [Abstract][Full Text] [Related]
4. Main B-cell epitopes of PvAMA-1 and PvMSP-9 are targeted by naturally acquired antibodies and epitope-specific memory cells in acute and convalescent phases of vivax malaria.
Soares RR; Nakaie CR; Rodrigues-da-Silva RN; da Silva RL; Lima-Junior JDC; Scopel KKG
Parasite Immunol; 2020 May; 42(5):e12705. PubMed ID: 32096238
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
Fonseca JA; McCaffery JN; Caceres J; Kashentseva E; Singh B; Dmitriev IP; Curiel DT; Moreno A
Vaccine; 2018 May; 36(20):2799-2808. PubMed ID: 29657070
[TBL] [Abstract][Full Text] [Related]
6. Induction of Multifunctional Broadly Reactive T Cell Responses by a Plasmodium vivax Circumsporozoite Protein Recombinant Chimera.
Cabrera-Mora M; Fonseca JA; Singh B; Oliveira-Ferreira J; Lima-Junior Jda C; Calvo-Calle JM; Moreno A
Infect Immun; 2015 Sep; 83(9):3749-61. PubMed ID: 26169267
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.
Bitencourt AR; Vicentin EC; Jimenez MC; Ricci R; Leite JA; Costa FT; Ferreira LC; Russell B; Nosten F; Rénia L; Galinski MR; Barnwell JW; Rodrigues MM; Soares IS
PLoS One; 2013; 8(2):e56061. PubMed ID: 23457498
[TBL] [Abstract][Full Text] [Related]
9. Antibody Responses Against
Matos ADS; Rodrigues-da-Silva RN; Soares IF; Baptista BO; de Souza RM; Bitencourt-Chaves L; Totino PRR; Sánchez-Arcila JC; Daniel-Ribeiro CT; López-Camacho C; Reyes-Sandoval A; Pratt-Riccio LR; Lima-Junior JDC
Front Immunol; 2019; 10():2230. PubMed ID: 31620136
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses.
Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET
Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
12. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
[TBL] [Abstract][Full Text] [Related]
13. Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7).
Cheng CW; Jongwutiwes S; Putaporntip C; Jackson AP
Malar J; 2019 Jun; 18(1):197. PubMed ID: 31196098
[TBL] [Abstract][Full Text] [Related]
14. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP1
Rocha MV; Françoso KS; Lima LC; Camargo TM; Machado RLD; Costa FTM; Rénia L; Nosten F; Russell B; Rodrigues MM; Soares IS
Vaccine; 2017 Apr; 35(18):2463-2472. PubMed ID: 28341111
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
[TBL] [Abstract][Full Text] [Related]
16. Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
George MT; Schloegel JL; Ntumngia FB; Barnes SJ; King CL; Casey JL; Foley M; Adams JH
mSphere; 2019 May; 4(3):. PubMed ID: 31092602
[TBL] [Abstract][Full Text] [Related]
17. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals.
Lima-Junior JC; Tran TM; Meyer EV; Singh B; De-Simone SG; Santos F; Daniel-Ribeiro CT; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2008 Dec; 26(51):6645-54. PubMed ID: 18832003
[TBL] [Abstract][Full Text] [Related]
18. B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.
Lima-Junior JC; Jiang J; Rodrigues-da-Silva RN; Banic DM; Tran TM; Ribeiro RY; Meyer VS; De-Simone SG; Santos F; Moreno A; Barnwell JW; Galinski MR; Oliveira-Ferreira J
Vaccine; 2011 Feb; 29(9):1801-11. PubMed ID: 21215342
[TBL] [Abstract][Full Text] [Related]
19. The
López C; Yepes-Pérez Y; Díaz-Arévalo D; Patarroyo ME; Patarroyo MA
Front Cell Infect Microbiol; 2018; 8():156. PubMed ID: 29868512
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli.
Sachdeva S; Ahmad G; Malhotra P; Mukherjee P; Chauhan VS
Infect Immun; 2004 Oct; 72(10):5775-82. PubMed ID: 15385477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
